NYSE:CNC - Centene Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$51.87 +1.64 (+3.26 %)
(As of 04/26/2019 12:50 PM ET)
Previous Close$50.23
Today's Range$50.39 - $51.90
52-Week Range$45.44 - $74.49
Volume338,116 shs
Average Volume5.37 million shs
Market Capitalization$21.43 billion
P/E Ratio14.65
Dividend YieldN/A
Beta1.26
Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. The company's Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which covers dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions, limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members in the Managed Care segment. Its Specialty Services segment provides pharmacy benefits management services; health, triage, wellness, and disease management services; and vision and dental, and management services, as well as care management software that automate the clinical, administrative, and technical components of care management programs. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.

Receive CNC News and Ratings via Email

Sign-up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
CUSIP15135B10
Phone314-725-4477

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$60.12 billion
Cash Flow$4.7851 per share
Book Value$28.16 per share

Profitability

Net Income$900 million

Miscellaneous

Employees47,300
Market Cap$21.43 billion
Next Earnings Date7/23/2019 (Estimated)
OptionableOptionable

Centene (NYSE:CNC) Frequently Asked Questions

What is Centene's stock symbol?

Centene trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNC."

When did Centene's stock split? How did Centene's stock split work?

Centene's stock split on the morning of Wednesday, February 6th 2019. The 2-1 split was announced on Tuesday, February 5th 2019. The newly minted shares were distributed to shareholders after the closing bell on Tuesday, February 5th 2019. An investor that had 100 shares of Centene stock prior to the split would have 200 shares after the split.

How were Centene's earnings last quarter?

Centene Corp (NYSE:CNC) issued its earnings results on Tuesday, April, 23rd. The company reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.32 by $0.07. The company earned $18.44 billion during the quarter, compared to analyst estimates of $17.44 billion. Centene had a return on equity of 14.60% and a net margin of 1.66%. The business's quarterly revenue was up 39.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.17 EPS. View Centene's Earnings History.

When is Centene's next earnings date?

Centene is scheduled to release their next quarterly earnings announcement on Tuesday, July 23rd 2019. View Earnings Estimates for Centene.

What guidance has Centene issued on next quarter's earnings?

Centene issued an update on its FY19 earnings guidance on Tuesday, April, 23rd. The company provided earnings per share guidance of $4.24-4.44 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.25. The company issued revenue guidance of $72.8-73.6 billion, compared to the consensus revenue estimate of $70.76 billion.Centene also updated its FY 2019 guidance to $4.24-4.44 EPS.

What price target have analysts set for CNC?

18 equities research analysts have issued 1 year target prices for Centene's shares. Their predictions range from $63.00 to $85.00. On average, they anticipate Centene's share price to reach $76.8025 in the next year. This suggests a possible upside of 49.0% from the stock's current price. View Analyst Price Targets for Centene.

What is the consensus analysts' recommendation for Centene?

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Centene in the last year. There are currently 3 hold ratings and 15 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Centene.

What are Wall Street analysts saying about Centene stock?

Here are some recent quotes from research analysts about Centene stock:
  • 1. According to Zacks Investment Research, "Centene’s momentum in revenue growth is likely to grow on the back of rising membership and expansion. The company boasts an impressive inorganic growth strategy driven by buyouts. Medical membership of the company has been rising over the past several quarters due to contract wins. Shares of the company have lost more than its industry in a year’s time. Over the last 30 days, the company has witnessed its 2019 and 2020 earnings estimates move north. However, rising operating costs remains a concern. Also, high debt level increases leverage risk. In 2019, the company expects its adjusted EPS to remain in between $4.11 and $4.31, down from 2018’s full year EPS of $7.08." (4/15/2019)
  • 2. Cantor Fitzgerald analysts commented, "We rate Centene Corporation (CNC) DCF-based price target of $145 per share. We continue to view Medicaid as a good growth opportunity. At the same time, CNC is building its Medicare Advantage business, increasing its footprint in individual exchange markets (and doing it profitably) and increasing its specialty offerings. $145 per share 12-month price target is based on DCF analysis." (12/13/2018)

Has Centene been receiving favorable news coverage?

News articles about CNC stock have trended somewhat positive on Friday, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Centene earned a daily sentiment score of 2.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an impact on the stock's share price in the next several days.

Are investors shorting Centene?

Centene saw a increase in short interest in the month of March. As of March 29th, there was short interest totalling 10,080,577 shares, an increase of 138.3% from the March 15th total of 4,230,824 shares. Based on an average daily trading volume, of 7,403,949 shares, the short-interest ratio is presently 1.4 days. Currently, 2.5% of the company's stock are short sold. View Centene's Current Options Chain.

Who are some of Centene's key competitors?

What other stocks do shareholders of Centene own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Centene investors own include NVIDIA (NVDA), Alibaba Group (BABA), UnitedHealth Group (UNH), Visa (V), Adobe (ADBE), Micron Technology (MU), Netflix (NFLX), Boeing (BA), Home Depot (HD) and Johnson & Johnson (JNJ).

Who are Centene's key executives?

Centene's management team includes the folowing people:
  • Mr. Michael Frederic Neidorff, Chairman & CEO (Age 76)
  • Mr. Jeffrey Alan Schwaneke CPA, CPA, Exec. VP, CFO & Treasurer (Age 43)
  • Ms. Brandy Lynn Burkhalter, Exec. VP of Operations (Age 46)
  • Mr. Mark J. Brooks, Exec. VP & Chief Information Officer (Age 49)
  • Mr. Jesse N. Hunter, Exec. VP & Chief Strategy Officer (Age 43)

Who are Centene's major shareholders?

Centene's stock is owned by a number of of retail and institutional investors. Top institutional investors include Strs Ohio (0.23%), Cortland Associates Inc. MO (0.15%), Hexavest Inc. (0.14%), BNP Paribas Arbitrage SA (0.10%), Deroy & Devereaux Private Investment Counsel Inc. (0.06%) and Nisa Investment Advisors LLC (0.06%). Company insiders that own Centene stock include Brandy Burkhalter, Christopher D Bowers, Jeffrey A Schwaneke, Jesse N Hunter, Keith H Williamson, Mark J Brooks, Michael F Neidorff, Richard A Gephardt, Robert K Ditmore and Stephen Wallace. View Institutional Ownership Trends for Centene.

Which institutional investors are selling Centene stock?

CNC stock was sold by a variety of institutional investors in the last quarter, including Avalon Advisors LLC, Scout Investments Inc., Assenagon Asset Management S.A., Columbus Circle Investors, First Hawaiian Bank, Leavell Investment Management Inc. and QUANTRES ASSET MANAGEMENT Ltd. Company insiders that have sold Centene company stock in the last year include Brandy Burkhalter, Christopher D Bowers, Jeffrey A Schwaneke, Keith H Williamson, Mark J Brooks, Michael F Neidorff and Robert K Ditmore. View Insider Buying and Selling for Centene.

Which institutional investors are buying Centene stock?

CNC stock was acquired by a variety of institutional investors in the last quarter, including Hexavest Inc., Strs Ohio, Cortland Associates Inc. MO, Deroy & Devereaux Private Investment Counsel Inc., BNP Paribas Arbitrage SA, Deltec Asset Management LLC, Nisa Investment Advisors LLC and BB&T Corp. View Insider Buying and Selling for Centene.

How do I buy shares of Centene?

Shares of CNC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Centene's stock price today?

One share of CNC stock can currently be purchased for approximately $51.56.

How big of a company is Centene?

Centene has a market capitalization of $21.30 billion and generates $60.12 billion in revenue each year. The company earns $900 million in net income (profit) each year or $3.54 on an earnings per share basis. Centene employs 47,300 workers across the globe.

What is Centene's official website?

The official website for Centene is http://www.centene.com.

How can I contact Centene?

Centene's mailing address is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. The company can be reached via phone at 314-725-4477 or via email at [email protected]


MarketBeat Community Rating for Centene (NYSE CNC)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  816 (Vote Outperform)
Underperform Votes:  533 (Vote Underperform)
Total Votes:  1,349
MarketBeat's community ratings are surveys of what our community members think about Centene and other stocks. Vote "Outperform" if you believe CNC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CNC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/26/2019 by MarketBeat.com Staff

Featured Article: Buyback

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel